Literature DB >> 10800788

Clinicopathological and biological assessment of lung cancers with pleural dissemination.

Y Ohta1, Y Tanaka, T Hara, M Oda, S Watanabe, J Shimizu, Y Watanabe.   

Abstract

BACKGROUND: This study provides the surgical outcome of lung cancer patients with pleural dissemination, with the assessment of the clinicopathological and biological prognostic factors.
METHODS: Forty-three patients who underwent operations were studied. Vascular endothelial growth factor (VEGF) and autocrine motility factor receptor (AMFR/gp78) expression was immunohistochemically evaluated.
RESULTS: In total, the overall 3 and 5-year survival rates were 31.4% and 13.1%, respectively. The patients who underwent the pleuropneumonectomy had a worse outcome than those who underwent limited operations (pleurectomy plus parenchymal resections were less than pneumonectomy). VEGF and AMFR/gp78 were highly expressed in primary tumors. Among the patients who underwent limited operations, pathological types other than adenocarcinoma and high expression of VEGF were significantly associated with a worse outcome. The pathological type was the only characteristic to retain a significant independent prognostic impact on overall survival.
CONCLUSIONS: The results imply the validation of limited operation for lung cancer with pleural dissemination for the local control. High frequency of VEGF and AMFR/gp78 expression conform to the interpretation that patients with pleural dissemination have a high-risk of systemic disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10800788     DOI: 10.1016/s0003-4975(99)01579-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  11 in total

1.  Evaluation of the 7th edition of the TNM classification for lung cancer at a single institution.

Authors:  Jia Wang; Nan Wu; Qingfeng Zheng; Yuan Feng; Shi Yan; Chao Lv; Shaolei Li; Yuzhao Wang; Yue Yang
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-28       Impact factor: 4.553

2.  Pulmonary resection for lung cancer with malignant pleural disease first detected at thoracotomy.

Authors:  Tatsuro Okamoto; Takekazu Iwata; Teruaki Mizobuchi; Hidehisa Hoshino; Yasumitsu Moriya; Shigetoshi Yoshida; Ichiro Yoshino
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

3.  Monoclonal antibodies against autocrine motility factor suppress gastric cancer.

Authors:  Hahn-Sun Jung; Su In Lee; Seung-Hoon Kang; Jin Sang Wang; Eun Hee Yang; Byungwook Jeon; Jayhyuk Myung; Ji Young Baek; Song-Kyu Park
Journal:  Oncol Lett       Date:  2017-04-13       Impact factor: 2.967

4.  Predictive factors related to pleural dissemination in non-small cell lung cancer.

Authors:  Nozomu Motono; Shun Iwai; Iijima Yoshihito; Katsuo Usuda; Sohsuke Yamada; Hidetaka Uramoto
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

5.  Survival Benefits for Pulmonary Adenocarcinoma With Malignant Pleural Effusion After Thoracoscopic Surgical Treatment: A Real-World Study.

Authors:  Xin Li; Mingbiao Li; Jinshuang Lv; Jinghao Liu; Ming Dong; Chunqiu Xia; Honglin Zhao; Song Xu; Sen Wei; Zuoqing Song; Gang Chen; Hongyu Liu; Jun Chen
Journal:  Front Oncol       Date:  2022-05-05       Impact factor: 5.738

6.  Accidental invisible intrathoracic disseminated pT4-M1a: a distinct lung cancer with favorable prognosis.

Authors:  Wen-Zhao Zhong; Wei Li; Xue-Ning Yang; Ri-Qiang Liao; Qiang Nie; Song Dong; Hong-Hong Yan; Xu-Chao Zhang; Hai-Yan Tu; Bin-Chao Wang; Jian Su; Jin-Ji Yang; Qing Zhou; Yi-Long Wu
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

7.  Management of occult malignant pleural disease firstly detected at thoracotomy for non-small cell lung cancer patients.

Authors:  Shaolei Li; Shanyuan Zhang; Miao Huang; Yuanyuan Ma; Yue Yang
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

8.  Surgical Resection of Primary Tumors Provides Survival Benefits for Lung Cancer Patients With Unexpected Pleural Dissemination.

Authors:  Liwen Fan; Haitang Yang; Ke Han; Yang Zhao; Wen Gao; Ralph A Schmid; Feng Yao; Heng Zhao
Journal:  Front Surg       Date:  2021-06-23

Review 9.  Gp78 E3 Ubiquitin Ligase: Essential Functions and Contributions in Proteostasis.

Authors:  Vibhuti Joshi; Arun Upadhyay; Amit Kumar; Amit Mishra
Journal:  Front Cell Neurosci       Date:  2017-08-25       Impact factor: 5.505

10.  Prediction of overall survival of non-small cell lung cancer with bone metastasis: an analysis of the Surveillance, Epidemiology and End Results (SEER) database.

Authors:  Si Shi; Hongwei Wang; Xiaohui Liu; Jinling Xiao
Journal:  Transl Cancer Res       Date:  2021-12       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.